-
Five Year Outcomes with Alemtuzumab Induction Therapy in Elderly Renal Transplant Recipients.
-
Five-Year Outcomes After Transplantation of Kidneys from Deceased Donors with Acute Kidney Injury.
-
Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated with Belatacept.
-
Forty-Six Consecutive Cases of Pure Live Donor Right or Extended Right Hepatectomy: Single Surgeon Initial 1-Year Experience.
-
Fosfomycin Tromeltamol (FOS) Is an Effective Alternative in Post Renal Transplant Urinary Tract Infection Prophylaxis Caused by Escherichia coli and Enterococcus faecalis without Increasing Resistance Rate.
-
FOXP3 rs3761548 A/C+A/A Genotype Is a Risk Factor for Steroid Resistant Rejection After Liver Transplantation.
-
Full Dose Cyclosporine Permanently Reverses Uncontrolled BK Viremia That Is Refractory to Tacrolimus Minimization.
-
Functional Gain in eGFR Among Living Kidney Donors and Its Association with Remaining Kidney Volume.
-
Functional Mystacial Pad Allograft Tolerance Induced and Maintained by Vascularized Bone Marrow Transplant.
-
Ganciclovir Resistant Cytomegalovirus Infection in Abdominal Tansplant Recipients.
- « Previous Page
- 1
- …
- 64
- 65
- 66
- 67
- 68
- …
- 181
- Next Page »